Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 75,364 | 55,696 | 20,547 | 141,209 | 110,463 |
| Depreciation Amortization | 1,408 | 931 | 462 | -9,602 | 876 |
| Income taxes - deferred | -22,355 | -31,469 | -13,705 | -40,191 | -36,333 |
| Accounts receivable | -15,653 | -10,591 | -7,843 | -12,853 | -18,594 |
| Accounts payable and accrued liabilities | 19,070 | 8,149 | 12,929 | -2,248 | 1,086 |
| Other Working Capital | -10,591 | -13,939 | -22,313 | 45,297 | 27,420 |
| Other Operating Activity | 56,305 | 40,290 | 15,051 | 76,455 | 53,319 |
| Operating Cash Flow | $103,548 | $49,067 | $5,128 | $198,067 | $138,237 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 81,762 | 67,117 | -3,067 | -588,310 | -111,193 |
| PPE Investments | -161 | -161 | -104 | -2,172 | -2,051 |
| Purchase Of Investment | N/A | N/A | N/A | 412,878 | N/A |
| Investing Cash Flow | $81,601 | $66,956 | $-3,171 | $-177,604 | $-113,244 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,168 | 15,965 | 1,740 | 9,616 | 7,195 |
| Common Stock Repurchased | -172,915 | -130,451 | -25,718 | -15,664 | -15,664 |
| Other Financing Activity | -36,403 | -28,251 | -15,825 | -22,301 | -15,316 |
| Financing Cash Flow | $-189,150 | $-142,737 | $-39,803 | $-28,349 | $-23,785 |
| Exchange Rate Effect | 1,474 | 1,794 | N/A | N/A | 530 |
| Beginning Cash Position | 127,665 | 127,665 | 127,665 | 135,551 | 135,551 |
| End Cash Position | 125,138 | 102,745 | 89,819 | 127,665 | 137,289 |
| Net Cash Flow | $-2,527 | $-24,920 | $-37,846 | $-7,886 | $1,738 |
| Free Cash Flow | |||||
| Operating Cash Flow | 103,548 | 49,067 | 5,128 | 198,067 | 138,237 |
| Capital Expenditure | -161 | -161 | -104 | -2,172 | -2,051 |
| Free Cash Flow | 103,387 | 48,906 | 5,024 | 195,895 | 136,186 |